TGFBR1 and cancer: Here, cancer cells were treated with the TGFBR1 inhibitor SB431542, and we found that the mRNA levels of PAI-1 in B16F10-C3 and 231-GFP cells cocultured with platelets were significantly decreased by approximately 85% and 60%, respectively (Figure 7E, Fig. S5C).